The Effect of manufacturer-to-consumer prescription drug advertisements: An exploratory investigation

Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing

Volumn 5, Issue 3, 2005, Pages 233-244

  Joseph, Mathew ^a   Stone, George ^b   Haper, Jill ^b   Stockwell, Emily ^b   Johnson, Kati ^b   Huckaby, Jennifer ^b  

^a University of South Alabama   (United States)

^b NONE

Author keywords

consumer awareness; direct to consumer; doctor patient relationships; DTC drug advertisements; effectiveness; FDA; pharmaceutical industry; positive and negative benefits; spending

Indexed keywords

EID: 84990350744     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5040235     Document Type: Article

References (28)

1. Findlay S. (2002) ‘Do advertisements really drive pharmaceutical sales? The true effects of DTC advertising remain a mystery’, Marketing Health Services, 22(1), 20–25.
2. Mintzes B. Barer M.L. Kazanjian A., et al(2002) ‘An assessment of the health system impacts of direct-to-consumer advertising of prescription medicines (DTCA)’, Executive Summary, Center for Health Services and Policy Research, www.cihr-irsc.gc.ca/e/documents/dtca_e.pdf (Accessed February 2005).
3. Rentas-Giusti L. (2002) ‘Powerful pain relief’, Caribbean Business, 22 August, 20–24.
4. Mintzes B. (2001) ‘Powerful pain relief’, Caribbean Business, 22 August, 20–24.
5. Mintzes B. Morris L. Kravitz R. (2002) ‘Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: Two site cross sectional survey’, British Medical Journal, 32(7), 278–280.
6. Hunt M. (1998) ‘Direct-to-consumer advertising of prescription drugs’, National Health Policy Forum, George Washington University, Washington, DC, USA, April.
7. Bell R. Wilkes M. Kravitz R. (1999) ‘Advertisement-induced prescription drug requests: Patients' anticipated reactions to a physician who refuses’, Journal of Family Practice, 48(6), 446–552.
8. Mintzes B. (2001) ‘Advertisement-induced prescription drug requests: Patients' anticipated reactions to a physician who refuses’, Journal of Family Practice, 48(6), 446–552.
9. Rentas-Giusti L. (2002) Journal of Family Practice.
10. Davis J. (2000) ‘Riskier than we think? The risk between risk statement completeness and perceptions of direct-to-consumer advertised prescription drugs’, Journal of Health Communications, 5, 349–369.
11. Doucette W. Schommer J. (1998) ‘Consumer preferences for drug information after direct-to-consumer advertising’, Drug Info, 32(4), 1081–1088.
12. Williams J. Hensel P. (1995) ‘Direct-to-consumer advertising of prescription drugs’, Journal of Health Care Marketing, 15(1), 35–41.
13. Shields T. (2003) ‘Drug-ad fight looms in congress’, Adweek (Midwest Edition), 44(4), 2.
14. National Institute for Health Care Management Research and Educational Foundation (2001) ‘Prescription drugs and mass media advertising, 2000’, Washington, DC, www.nihcm.org. (Accessed February 2005).
15. National Institute for Health Care Management Research and Educational Foundation (2001) ‘Prescription drugs and mass media advertising, 2000’, Washington, DC, www.nihcm.org. (Accessed February 2005).
16. National Survey of Consumer Reactions to Direct-to-Consumer Advertising (1998) ‘Year two: A national survey of consumer reactions to direct-to-consumer advertising’, Prevention Magazine, Rodale Press, Emmaus, Pennsylvania.
17. Prevention International Survey on Wellness and Consumer Reaction to DTC Advertising of Rx Drugs (2000/2001) (1999) ‘Prevention international survey on wellness and consumer reaction to DTC advertising of Rx drugs’, Prevention Magazine, Rodale Press, Emmaus, Pennsylvania.
18. Mintzes B. (2001) ‘Prevention international survey on wellness and consumer reaction to DTC advertising of Rx drugs’, Prevention Magazine, Rodale Press, Emmaus, Pennsylvania.
19. Lipsky M. Taylor C. (1997) ‘The opinions and experiences of family physicians regarding direct-to-consumer advertising’, Journal of Family Practitioners, 45(6), 495–499.
20. Rentas-Giusti L. (2002) Journal of Family Practitioners.
21. Findlay S. (2002) Journal of Family Practitioners.
22. Spurgeon D. (1999) ‘Doctors feel pressurized by direct-to-consumer advertising’, British Medical Journal, 319(7221), 1321.
23. US FDA, Division of Drug Marketing, Advertising and Communication (1999) ‘Consumer responses to direct-to-consumers prescription drug advertising’, US FDA. Results posted at www.fda.gov/cder/ddmac/research.htm. (Accessed February 2005).
24. Miller S. (1998) ‘DTC advertisements provide the right prescription’, Brandweek, 39(26), 14.
25. Liebeskin K. (2000) ‘Targeted advertisements for new drugs a shot in the arm’, Advertising, 47(48), 33–37.
26. Weeks W. Wallace A. Kimberly S. (2001) ‘The changing face of pharmaceutical advertising’, Marketing Health Services, 21(3), 27–30.
27. Alperstein M. Peyrot M. (1993) ‘Consumer awareness of prescription drug advertising’, Journal of Advertising Research, July/August.
28. US FDA, (1999) Journal of Advertising Research.